Share on LinkedInShare on LinkedIn

ARTICLE · 16 APRIL 2019

European Data Protection Board Clarifies Consent Under Clinical Trial Regulation And General Data Protection Regulation

Van Bael & Bellis
Van Bael & Bellis
Contributor
Van Bael & Bellis

Van Bael & Bellis

Van Bael & Bellis is a leading independent law firm headquartered in Brussels with offices in...

View firm profile
Explore more from Van Bael & Bellis

The entry into force of the CTR depends on the development of the EU clinical trial portal and database.

European UnionPrivacy

In its opinion of 23 January 2019 (the "Opinion"), the European Data Protection Board ("EDPB") clarifies the interplay between Clinical Trial Regulation 536/2014 (the "CTR") and the General Data Protection Regulation ("GDPR"). In particular, the EDPB provides guidance on the legal basis for (i) the use of personal data in the context of the clinical trial protocol and (ii) the secondary use of clinical data outside the clinical trial protocol for scientific purposes. The Opinion was requested by the European Commission for its Q & A on the interplay between the CTR and the GDPR.

The entry into force of the CTR depends on the development of the EU clinical trial portal and database. When it starts to apply, the CTR will replace current Directive 2001/20/EC. The simultaneous application of the CTR and the GDPR causes practical difficulties for companies and researchers, including the questions of when and for what purposes consent is required. The EDPB explains

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from